Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen A Veverka

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 15, 2024
Eblasakimab, an Anti-IL‑13Rα1 Antibody, Reduces Atopy-Associated Serum Biomarkers in Moderate‑to‑Severe Atopic DermatitisFerda Cevikbas, Alison Ward, Karen A Veverka
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 1, 2013
Absorption, distribution, metabolism and excretion of the novel SARM GTx-024 [(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide] in ratsJuhyun Kim, Ronghua Wang, Karen A Veverka, et al.
Journal of Drugs in Dermatology : JDD|August 21, 2018
Patient-Reported Satisfaction With the Fixed Combination Calcipotriene/Betamethasone Dipropionate Foam for Plaque PsoriasisJoe Gorelick, Wendy Cantrell, Kristine Kucera, et al.
The Journal of Dermatological Treatment|October 12, 2018
Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United StatesJashin J Wu, Karen A Veverka, Minyi Lu, et al.
The Journal of Dermatological Treatment|January 29, 2020
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE)Sascha Gerdes, Manuel Velasco, Jashin J Wu, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2021
Calcipotriene Plus Betamethasone Dipropionate Foam for Mild Psoriasis: Pooled Results from Three Randomized TrialsKaren A Veverka, Jes B Hansen, Maria Yaloumis, et al.
Journal of the American Academy of Dermatology|May 21, 2020
PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasisLinda Stein Gold, Jes B Hansen, Dharm Patel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 13, 2023
Targeting type 2 immune activation beyond atopic dermatitisDonald Y M Leung, Paola Facheris, Karen A Veverka, et al.
Journal of Drugs in Dermatology : JDD|August 18, 2020
Real-World Effectiveness and Safety of Field- and Lesion-Directed Treatments for Actinic KeratosisJes B Hansen, Thomas Larsson, Nikeshia Dunkelly-Allen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 6, 2011
Drug interaction potential of toremifene and N-desmethyltoremifene with multiple cytochrome P450 isoformsJuhyun Kim, Concepcion Peraire, Josep Solà, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 15, 2024
Eblasakimab, an Anti-IL‑13Rα1 Antibody, Reduces Atopy-Associated Serum Biomarkers in Moderate‑to‑Severe Atopic DermatitisFerda Cevikbas, Alison Ward, Karen A Veverka
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 1, 2013
Absorption, distribution, metabolism and excretion of the novel SARM GTx-024 [(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide] in ratsJuhyun Kim, Ronghua Wang, Karen A Veverka, et al.
Journal of Drugs in Dermatology : JDD|August 21, 2018
Patient-Reported Satisfaction With the Fixed Combination Calcipotriene/Betamethasone Dipropionate Foam for Plaque PsoriasisJoe Gorelick, Wendy Cantrell, Kristine Kucera, et al.
The Journal of Dermatological Treatment|October 12, 2018
Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United StatesJashin J Wu, Karen A Veverka, Minyi Lu, et al.
The Journal of Dermatological Treatment|January 29, 2020
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE)Sascha Gerdes, Manuel Velasco, Jashin J Wu, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2021
Calcipotriene Plus Betamethasone Dipropionate Foam for Mild Psoriasis: Pooled Results from Three Randomized TrialsKaren A Veverka, Jes B Hansen, Maria Yaloumis, et al.
Journal of the American Academy of Dermatology|May 21, 2020
PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasisLinda Stein Gold, Jes B Hansen, Dharm Patel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 13, 2023
Targeting type 2 immune activation beyond atopic dermatitisDonald Y M Leung, Paola Facheris, Karen A Veverka, et al.
Journal of Drugs in Dermatology : JDD|August 18, 2020
Real-World Effectiveness and Safety of Field- and Lesion-Directed Treatments for Actinic KeratosisJes B Hansen, Thomas Larsson, Nikeshia Dunkelly-Allen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 6, 2011
Drug interaction potential of toremifene and N-desmethyltoremifene with multiple cytochrome P450 isoformsJuhyun Kim, Concepcion Peraire, Josep Solà, et al.
Pageof 3